MedPath

A clinical study to assess cutting and healing effect of apamargadi ksharasutra in patients with pilonidal sinus.

Phase 2/3
Not yet recruiting
Conditions
Pilonidal cyst and sinus without abscess. Ayurveda Condition: NADIVRANAH,
Registration Number
CTRI/2022/07/043658
Lead Sponsor
Government Ayurveda College hospital Tripunithura
Brief Summary

The trial will be conducted to assess the cutting and healing effect of apamargadi  ksharasutra, prepared out of apamarga, palasha, kadalikanda, swarjika kshara and shankhanabhi bhasma  [as per Gada nigraha by Shodala] in pilonidal sinus. The study will be conducted in participants who are clinically diagnosed with pilonidal sinus, attending the OP and IP, Department of Salyatantra, Government Ayurveda College Tripunithura, in the age group 15 to 40 years, who satisfy the inclusion and exclusion criteria. The study duration is till cut through of the pilonidal  tract or till a maximum of 70 days. Primary outcomes are Unit Cutting Time and healing effect out of which the former is assessed by the formula - Total number of days for cut through/Initial length of the ksharasutra in cm and the latter is assessed by measuring length of resultant wound after ksharasutra cut through. Secondary outcomes include effect of this ksharasutra in itching, pain and discharge in the conditions, which are assessed by the grading prepared by Paul O’ Madson and Peter. Primary outcomes except Unit Cutting Time and healing effect are assessed on weekly from 0th day till 70th day and Unit Cutting Time and healing effect will be assessed on the basis of length of ksharasutra and length of resultant wound  after succeeding changes from 7th day onwards till 70th day. Secondary outcomes will be assessed from 0th day (day of application of the ksharasutra) till 70th day.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Both male and female participants in the age group of 15 years to 40 years will be enrolled.
  • Participants who have pilonidal sinus in sacrococcygeal diagnosed by clinical examination.
  • Participants with written informed consent/assent.
Exclusion Criteria
  • Participants below 15 years of age and above 40 years of age.
  • Participants with uncontrolled Diabetes mellitus and Hypertension.
  • Known HIV/hepatitis B/VDRL positive participants will be excluded.
  • Known patients with tuberculosis.
  • Known patients with bleeding disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Unit Cutting Time of the ksharasutra measured7th day, 14th day, 21st day, 28th day, 35th day, | 42nd day, 49th day, 56th day, 63rd day, 70th | days for assessing Unit | Cutting Time. For assessing healing effect, 0th | day will also be considered (Day of application of | the ksharasutra)
by the formula (Total no of days for cut through/Initial length of ksharasutra in7th day, 14th day, 21st day, 28th day, 35th day, | 42nd day, 49th day, 56th day, 63rd day, 70th | days for assessing Unit | Cutting Time. For assessing healing effect, 0th | day will also be considered (Day of application of | the ksharasutra)
cm) and healing7th day, 14th day, 21st day, 28th day, 35th day, | 42nd day, 49th day, 56th day, 63rd day, 70th | days for assessing Unit | Cutting Time. For assessing healing effect, 0th | day will also be considered (Day of application of | the ksharasutra)
effect of ksharasutra assessed by measuring length of resultant wound.7th day, 14th day, 21st day, 28th day, 35th day, | 42nd day, 49th day, 56th day, 63rd day, 70th | days for assessing Unit | Cutting Time. For assessing healing effect, 0th | day will also be considered (Day of application of | the ksharasutra)
Secondary Outcome Measures
NameTimeMethod
Effect of ksharasutra in discharge, itching and pain.0th day, 7th day, 14th day, 21st day, 28th day,

Trial Locations

Locations (1)

Government Ayurveda College Hospital, Tripunithura

🇮🇳

Ernakulam, KERALA, India

Government Ayurveda College Hospital, Tripunithura
🇮🇳Ernakulam, KERALA, India
Mini M S
Principal investigator
8848213949
minimohananm@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.